BeOne Medicines (BEIGF) Deferred Taxes (2017 - 2023)
BeOne Medicines (BEIGF) reported Deferred Taxes of -$46000.0 for Q4 2023, down 102.74% year-over-year from $1.7 million in Q4 2022, and down 106.13% quarter-over-quarter from $750000.0 in Q3 2023.
BeOne Medicines (BEIGF) Deferred Taxes (2017 - 2023) Analysis & Trends
BeOne Medicines (BEIGF) has 7 years of Deferred Taxes data on file, last reported at -$46000.0 in Q4 2023.
- Deferred Taxes for Q4 2023 came in at -$46000.0, down 102.74% year-over-year; the trailing twelve-month figure through Dec 2023 was $689000.0 (down 66.54% YoY), and the FY2025 annual result was $9.5 million, down 63.56% from the prior year.
- Deferred Taxes slipped to -$46000.0 in Q4 2023 per BEIGF's latest filing, from $750000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $14.8 million in Q3 2021 and troughed at -$12.3 million in Q1 2021.
- A 5-year average of -$142300.0 and a median of -$48500.0 in 2023 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2021 and 2022: Deferred Taxes sank 5847.09% in 2021, then jumped 941.67% in 2022.
- A 5-year view of Deferred Taxes shows it stood at $4.1 million in 2019, then surged by 119.97% to $9.0 million in 2020, then slumped by 89.99% to $903000.0 in 2021, then surged by 85.94% to $1.7 million in 2022, then slumped by 102.74% to -$46000.0 in 2023.
- Business Quant data shows BEIGF's Deferred Taxes at -$46000.0 in Q4 2023, $750000.0 in Q3 2023, and -$51000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | -51,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | 505,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 903,000.00 |
| Sep 30, 2021 | 14.79 Mn |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -12.25 Mn |
| Dec 31, 2020 | 9.02 Mn |
| Sep 30, 2020 | -7.70 Mn |
| Jun 30, 2020 | -854,000.00 |
| Mar 31, 2020 | -206,000.00 |
| Dec 31, 2019 | 4.10 Mn |
| Sep 30, 2019 | -11.88 Mn |
| Jun 30, 2019 | -473,000.00 |
| Mar 31, 2019 | -983,000.00 |